SRR1319672
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Female
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- DNA_REPAIR+0.188
- KRAS_SIGNALING_DN+0.074
- UNFOLDED_PROTEIN_RESPONSE+0.017
- MITOTIC_SPINDLE+0.013
- PROTEIN_SECRETION+0.004
- MYC_TARGETS_V2+0.001
- PI3K_AKT_MTOR_SIGNALING-0.007
- HEME_METABOLISM-0.026
- MYOGENESIS-0.036
- MYC_TARGETS_V1-0.039
Top 10 suppressed
- INTERFERON_ALPHA_RESPONSE-0.623
- INFLAMMATORY_RESPONSE-0.535
- IL6_JAK_STAT3_SIGNALING-0.502
- INTERFERON_GAMMA_RESPONSE-0.501
- TNFA_SIGNALING_VIA_NFKB-0.498
- ANGIOGENESIS-0.490
- ALLOGRAFT_REJECTION-0.481
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.470
- KRAS_SIGNALING_UP-0.437
- APOPTOSIS-0.421
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1359367 | GTEX | — | 0.988 |
| 2 | SRR1441224 | GTEX | — | 0.987 |
| 3 | SRR1394450 | GTEX | — | 0.987 |
| 4 | SRR1401552 | GTEX | — | 0.986 |
| 5 | SRR1464305 | GTEX | — | 0.985 |
| 6 | SRR1352415 | GTEX | — | 0.984 |
| 7 | SRR1477385 | GTEX | — | 0.984 |
| 8 | SRR1490568 | GTEX | — | 0.983 |
| 9 | SRR820468 | GTEX | — | 0.983 |
| 10 | SRR1361736 | GTEX | — | 0.983 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 6 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| DNA_REPAIR | 0.188 | Idelalisib | — uncovered |
| KRAS_SIGNALING_DN | 0.074 | Remibrutinib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.017 | Idelalisib | — uncovered |
| MITOTIC_SPINDLE | 0.013 | Inavolisib | — uncovered |
| PROTEIN_SECRETION | 0.004 | Remibrutinib | — uncovered |
| MYC_TARGETS_V2 | 0.001 | Idelalisib | — uncovered |